Disclaimer

CCHF in Afghanistan – Key Metrics

Overall burden of CCHF in Afghanistan 2022-2025, as of 2025, Epi-week 14

🇦🇫 Key Metrics by Year with Totals
Indicator 2022 2023 2024 2025 Overall Trends
Suspected Cases 389.0 1,243.0 1,221.0 71.0 2,924.0
Confirmed 103.0 383.0 271.0 11.0 768.0
Not confirmed 286.0 860.0 573.0 44.0 1,763.0
% Confirmed 26.5 30.8 32.1 20.0 30.3
Death 15.0 114.0 95.0 2.0 226.0
Alive 374.0 1,129.0 1,126.0 69.0 2,698.0
% Dead 3.9 9.2 7.8 2.8 7.7
Females 87.0 387.0 386.0 28.0 888.0
Males 302.0 856.0 835.0 43.0 2,036.0
% Female 22.4 31.1 31.6 39.4 30.4

Source: Afghanistan CDC.

  • Since 2022, a total of 2924 suspected cases suspected CCHF cases were reported in Afghanistan.

  • A total of 768 confirmed cases CCHF confirmed cases were reported among suspected cases, leading to a positivity rate of 26%.

  • Overall, 226 deaths deaths among suspected cases ( CFR 8% ). If we were to assume that these were among confirmed cases, this would be a 29% CFR .

CCHF Situation Summary in 2025: Most Recent

🇦🇫 Key Metrics by Week with Totals
Indicator 1 2 3 4 5 6 7 8 9 10 11 12 13 14 16 17 Overall Trends
Suspected Cases 7.0 3.0 8.0 3.0 2.0 - 5.0 6.0 5.0 10.0 2.0 12.0 5.0 3.0 - - 71.0
Confirmed - - - - - - - 2.0 - 3.0 - 5.0 1.0 - - - 11.0
Not confirmed 5.0 2.0 7.0 2.0 1.0 - 4.0 3.0 4.0 5.0 2.0 5.0 4.0 - - - 44.0
% Confirmed - - - - - - - 40.0 - 37.5 - 50.0 20.0 - - - 20.0
Death 1.0 - - - - - 1.0 - - - - - - - - - 2.0
Alive 6.0 3.0 8.0 3.0 2.0 - 4.0 6.0 5.0 10.0 2.0 12.0 5.0 3.0 - - 69.0
% Dead 14.3 - - - - - 20.0 - - - - - - - - - 2.8
Females 6.0 2.0 3.0 1.0 - - - 2.0 2.0 7.0 - 4.0 - 1.0 - - 28.0
Males 1.0 1.0 5.0 2.0 2.0 - 5.0 4.0 3.0 3.0 2.0 8.0 5.0 2.0 - - 43.0
% Female 85.7 66.7 37.5 33.3 - - - 33.3 40.0 70.0 - 33.3 - 33.3 - - 39.4

Source: Afghanistan CDC.

CCHF Situation Summary in 2022-2025: Monthly Summary

🇦🇫 Key Metrics by Month with Totals
Indicator Jan Feb Mar Apr Overall Trends
Suspected Cases 16.0 16.0 32.0 - 64.0
Confirmed - 2.0 9.0 - 11.0
Not confirmed 12.0 11.0 16.0 - 39.0
% Confirmed - 15.4 36.0 - 22.0
Death - 1.0 - - 1.0
Alive 16.0 15.0 32.0 - 63.0
% Dead - 6.2 - - 1.6
Females 6.0 4.0 12.0 - 22.0
Males 10.0 12.0 20.0 - 42.0
% Female 37.5 25.0 37.5 - 34.4

Source: Afghanistan CDC.

🇦🇫 Key Metrics by Month with Totals
Indicator Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Overall Trends
Suspected Cases 26.0 21.0 17.0 44.0 80.0 282.0 301.0 170.0 160.0 59.0 31.0 18.5 1,209.5
Confirmed - 1.0 1.0 4.0 15.0 102.0 81.0 36.0 11.0 11.0 6.0 1.5 269.5
Not confirmed 18.0 16.0 12.0 23.0 62.0 131.0 73.0 79.0 87.0 39.0 20.0 9.0 569.0
% Confirmed - 5.9 7.7 14.8 19.5 43.8 52.6 31.3 11.2 22.0 23.1 14.3 32.1
Death - - 1.0 1.0 4.0 29.0 28.0 15.0 11.0 4.0 1.0 1.0 95.0
Alive 26.0 21.0 16.0 43.0 76.0 253.0 273.0 155.0 149.0 55.0 30.0 17.5 1,114.5
% Dead - - 5.9 2.3 5.0 10.3 9.3 8.8 6.9 6.8 3.2 5.4 7.9
Females 6.0 7.0 9.0 19.0 22.0 62.0 105.0 45.0 71.0 16.0 8.0 11.0 381.0
Males 20.0 14.0 8.0 25.0 58.0 220.0 196.0 125.0 89.0 43.0 23.0 7.5 828.5
% Female 23.1 33.3 52.9 43.2 27.5 22.0 34.9 26.5 44.4 27.1 25.8 59.5 31.5

Source: Afghanistan CDC.

🇦🇫 Key Metrics by Month with Totals
Indicator Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Overall Trends
Suspected Cases 2.0 4.0 2.0 52.0 194.0 296.0 295.0 147.0 123.0 86.0 30.0 12.0 1,243.0
Confirmed - - - 12.0 81.0 130.0 81.0 48.0 6.0 24.0 1.0 - 383.0
Not confirmed 2.0 4.0 2.0 40.0 113.0 166.0 214.0 99.0 117.0 62.0 29.0 12.0 860.0
% Confirmed - - - 23.1 41.8 43.9 27.5 32.7 4.9 27.9 3.3 - 30.8
Death - - - - 4.0 19.0 55.0 18.0 9.0 5.0 4.0 - 114.0
Alive 2.0 4.0 2.0 52.0 190.0 277.0 240.0 129.0 114.0 81.0 26.0 12.0 1,129.0
% Dead - - - - 2.1 6.4 18.6 12.2 7.3 5.8 13.3 - 9.2
Females - 4.0 2.0 36.0 25.0 61.0 117.0 66.0 44.0 16.0 13.0 3.0 387.0
Males 2.0 - - 16.0 169.0 235.0 178.0 81.0 79.0 70.0 17.0 9.0 856.0
% Female - 100.0 100.0 69.2 12.9 20.6 39.7 44.9 35.8 18.6 43.3 25.0 31.1

Source: Afghanistan CDC.

🇦🇫 Key Metrics by Month with Totals
Indicator Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Overall Trends
Suspected Cases - - - 12.0 51.0 52.0 114.0 86.0 30.0 27.0 12.0 5.0 389.0
Confirmed - - - 4.0 5.0 25.0 18.0 34.0 10.0 7.0 - - 103.0
Not confirmed - - - 8.0 46.0 27.0 96.0 52.0 20.0 20.0 12.0 5.0 286.0
% Confirmed - - - 33.3 9.8 48.1 15.8 39.5 33.3 25.9 - - 26.5
Death - - - 1.0 1.0 6.0 6.0 1.0 - - - - 15.0
Alive - - - 11.0 50.0 46.0 108.0 85.0 30.0 27.0 12.0 5.0 374.0
% Dead - - - 8.3 2.0 11.5 5.3 1.2 - - - - 3.9
Females - - - 2.0 15.0 13.0 23.0 18.0 3.0 3.0 7.0 3.0 87.0
Males - - - 10.0 36.0 39.0 91.0 68.0 27.0 24.0 5.0 2.0 302.0
% Female - - - 16.7 29.4 25.0 20.2 20.9 10.0 11.1 58.3 60.0 22.4

Source: Afghanistan CDC.

CCHF seasonal incidence 2022-2025, as of 2025, Epi-week 14

  • Higher incidence of both suspected and confirmed cases reported from mid-May to end of September.
  • 81% of all suspected cases have been reported between epi-weeks 20 and 40.
  • 88% of all confirmed cases have been reported between epi-weeks 20 and 40.
  • In 2025, as of epi-week 14, 11 confirmed cases have been reported, a 450% increase compared to same period 2024.
  • Higher incidence of both suspected and confirmed cases reported from mid-May to end of September.
  • 81% of all suspected cases have been reported between epi-weeks 20 and 40.
  • 88% of all confirmed cases have been reported between epi-weeks 20 and 40.
  • In 2025, as of epi-week 14, 11 confirmed cases have been reported, a 450% increase compared to same period 2024.

Cases by Confirmation Status

  • Since 2022, a total of 2924 suspected cases suspected CCHF cases were reported in Afghanistan.

  • A total of 768 confirmed cases CCHF confirmed cases were reported among suspected cases, leading to a positivity rate of 26%.

  • Overall, 226 deaths deaths among suspected cases ( CFR 8% ). If we were to assume that these were among confirmed cases, this would be a 29% CFR .

CCHF in Afghanistan – Weekly Figures

Suspected Cases by Outcome and Epi-week

  • From sitrep information, it is not clear if death are reported among suspected cases or only among confirmed cases.

  • Among suspected cases, CFR is 8% .

  • If calculated only among confirmed cases, CFR would be 29%.

  • From sitrep information, it is not clear if death are reported among suspected cases or only among confirmed cases.

  • Among suspected cases, CFR is 8% .

  • If calculated only among confirmed cases, CFR would be 29%.

  • From sitrep information, it is not clear if death are reported among suspected cases or only among confirmed cases.

  • Among suspected cases, CFR is 8% .

  • If calculated only among confirmed cases, CFR would be 29%.

  • From sitrep information, it is not clear if death are reported among suspected cases or only among confirmed cases.

  • Among suspected cases, CFR is 8% .

  • If calculated only among confirmed cases, CFR would be 29%.

Suspected Cases by Sex and Epi-week

  • Overall, 70% of suspected CCHF cases are males.
  • As comparison, in 🇮🇶 Iraq approx. 59% of CCHF cases are males.
  • Higher rate in Afghanistan may be explained by socio-economic roles of males, gender-bias in access to care and services and other factors.
  • Overall, 70% of suspected CCHF cases are males.
  • As comparison, in 🇮🇶 Iraq approx. 59% of CCHF cases are males.
  • Higher rate in Afghanistan may be explained by socio-economic roles of males, gender-bias in access to care and services and other factors.
  • Overall, 70% of suspected CCHF cases are males.
  • As comparison, in 🇮🇶 Iraq approx. 59% of CCHF cases are males.
  • Higher rate in Afghanistan may be explained by socio-economic roles of males, gender-bias in access to care and services and other factors.
  • Overall, 70% of suspected CCHF cases are males.
  • As comparison, in 🇮🇶 Iraq approx. 59% of CCHF cases are males.
  • Higher rate in Afghanistan may be explained by socio-economic roles of males, gender-bias in access to care and services and other factors.

Suspected CCHF Cases with Samples Tested in Laboratory

  • Overall, 68% of suspected cases were tested.
  • The proportion of cases tested ranges from 88% in 2023 to 69% in 2024.
  • From informal reports, limited testing can be explained by lack of kit availability.
  • Methods for testing (PCR and/or IgM and/or IgG) is not indicated in a systematic matter. Both would be needed, especially if patients present late to health facilities.
  • Number of samples tested in 2022 is not reported in sitrep.
  • Overall, 68% of suspected cases were tested.
  • The proportion of cases tested ranges from 88% in 2023 to 69% in 2024.
  • From informal reports, limited testing can be explained by lack of kit availability.
  • Methods for testing (PCR and/or IgM and/or IgG) is not indicated in a systematic matter. Both would be needed, especially if patients present late to health facilities.
  • Number of samples tested in 2022 is not reported in sitrep.
  • Overall, 68% of suspected cases were tested.
  • The proportion of cases tested ranges from 88% in 2023 to 69% in 2024.
  • From informal reports, limited testing can be explained by lack of kit availability.
  • Methods for testing (PCR and/or IgM and/or IgG) is not indicated in a systematic matter. Both would be needed, especially if patients present late to health facilities.
  • Number of samples tested in 2022 is not reported in sitrep.

Suspected Cases by Laboratory Confirmation and Epi-week




Indicator 2024 2025 Change (%)
Suspected Cases 94 71 ️↘️ -24.5%
Death 2 2 ️↔︎️ 0%
Suspected tested 63 55 ️↘️ -12.7%
Confirmed 5 11 ↗️ 120%
% Suspected tested 67 77 ↗️ 15.6%
% Confirmed among tested 8 20 ↗️ 152%




Indicator 2023 2024 Change (%)
Suspected Cases 1,243 1,221 ️↘️ -1.8%
Death 114 95 ️↘️ -16.7%
Suspected tested 1,098 844 ️↘️ -23.1%
Confirmed 383 271 ️↘️ -29.2%
% Suspected tested 88 69 ️↘️ -21.7%
% Confirmed among tested 35 32 ️↘️ -7.9%




Indicator 2022 2023 Change (%)
Suspected Cases 389 1,243 ↗️ 219.5%
Death 15 114 ↗️ 660%
Confirmed 103 383 ↗️ 271.8%
Suspected tested 1,098
% Suspected tested 88
% Confirmed among tested 35

CCHF in Afghanistan – Yearly report

Suspected cases by Sex

Suspected cases by Outcome

Suspected cases by confirmation status

Suspected Cases by Testing Status and Epi-week

Thank you

Any questions or suggestions? Contact us: Anaïs Legand and Antoine Chaillon